| Ytd | -8.69% | |
| 1y | -20.49% |
| Open | 0.44 | Prev Close | 0.44 | Low | 0.44 | High | 0.47 | Mkt Cap | 49.72M |
| Vol | 8.41K | Avg Vol | 52.77K | EPS | 0.88 | P/E | 0.52 | Forward P/E | N/A |
| Beta | 2.73 | Short Ratio | 0.06 | Inst. Own | 1.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.46 | 200-d Avg | 0.51 | 1yr Est | 0.00 |
IBO News
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-
Impact BioMedical (AMEX:IBO) reported quarterly losses of $(0.02) per share. This is a 81.82 percent
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an inve
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an inve
HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced th
PAVS stock rose 65.6% in pre-market trading after ending sales agreement with A.G.P/Alliance Global
Faraday Future Intelligent Electric shares up 54.8% in pre-market trading after SEC investigation en
Dow down 800 points, S&P 500 and NASDAQ also fall. Energy sector rises, healthcare dips. BJ repo
US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6
Shares of Veeva Systems Inc (NYSE: VEEV) gained 11.3% in pre-market trading on upbeat Q4 results and
Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio L
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that
Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $
On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceuti
